<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: MicroRNAs (miRNA) have potential as prognostic biomarkers and therapeutic targets in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>A study was undertaken to investigate the association between miRNA expression patterns and the prognosis and therapeutic outcome of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: miRNA expression profiling in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>, <z:mpath ids='MPATH_270'>adenoma</z:mpath> and <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal tissues was performed to identify <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-related miRNAs in the course of colorectal malignant changes </plain></SENT>
<SENT sid="3" pm="."><plain>Quantitative reverse transcription PCR (qRT-PCR) assays were used to measure <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-related miRNA and to assess its association with survival and response to adjuvant chemotherapy in 239 patients </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, to validate the findings, associations of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-related miRNA with clinical characteristics of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> were analysed in 185 patients by in situ hybridisation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e>) analysis </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Only one miR-150 was found to show a decrease in expression levels in the three tissue groups (<z:mpath ids='MPATH_458'>normal</z:mpath>, <z:mpath ids='MPATH_270'>adenoma</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue) in parallel with increasing <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> of the colorectal tissue </plain></SENT>
<SENT sid="6" pm="."><plain>In both <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> and qRT-PCR analysis, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissue had reduced levels of miR-150 expression compared with paired non-cancerous tissue, which indicated that the levels of miR-150 expression were associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, patients whose <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> had low miR-150 expression had shorter survival and a worse response to adjuvant chemotherapy than patients whose <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> had high miRNA expression </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The miR-150 expression status of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> is associated with survival and response to adjuvant chemotherapy </plain></SENT>
<SENT sid="9" pm="."><plain>It is suggested that miR-150 should be considered as a potential biomarker associated with the prognosis and therapeutic outcome in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>